{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:57:49Z","timestamp":1788904669406,"version":"build-2803163510"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jconrel.2022.08.020","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T19:38:55Z","timestamp":1660765135000},"page":"107-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["From vaccines to nanovaccines: A promising strategy to revolutionize rheumatoid arthritis treatment"],"prefix":"10.1016","volume":"350","author":[{"given":"Nan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziye","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Younas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.08.020_bb0005","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay4014","article-title":"The science and medicine of human immunology","volume":"369","author":"Pulendran","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2021.08.011","article-title":"Nanomedicine based approaches for combating viral infections","volume":"338","author":"Shah","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1559","article-title":"Nanovaccines for cancer immunotherapy","volume":"11","author":"Zhang","year":"2019","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0020","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tips.2004.06.010","article-title":"A common vaccine for fighting neurodegenerative disorders: recharging immunity for homeostasis","volume":"25","author":"Schwartz","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0025","doi-asserted-by":"crossref","first-page":"852","DOI":"10.4161\/hv.28578","article-title":"Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?","volume":"10","author":"Romero-Ramos","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0030","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/nn405033r","article-title":"A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease","volume":"8","author":"Hunter","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.nano.2016.09.007","article-title":"An antigen-encapsulating nanoparticle platform for TH1\/17 immune tolerance therapy","volume":"13","author":"McCarthy","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0040","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2015.01.006","article-title":"Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice","volume":"62","author":"Carambia","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/BOR.0000000000000281","article-title":"Vaccinations for rheumatoid arthritis","volume":"28","author":"Friedman","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0050","doi-asserted-by":"crossref","first-page":"R171","DOI":"10.1186\/ar4358","article-title":"Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis","volume":"15","author":"Crnkic Kapetanovic","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/annrheumdis-2014-207191","article-title":"The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis","volume":"75","author":"Winthrop","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.phrs.2015.08.003","article-title":"Vaccines, adjuvants and autoimmunity","volume":"100","author":"Guimar\u00e3es","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.05.013","article-title":"Analysis of the PD-1\/PD-L1 axis in human autoimmune thyroid disease: insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity","volume":"103","author":"Alvarez-Sierra","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jbspin.2018.12.006","article-title":"Trained immunity and autoimmune disease: did eve sin before Adam?","volume":"86","author":"Berthelot","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.10.025","article-title":"PD-1 immunobiology in systemic lupus erythematosus","volume":"97","author":"Curran","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2018021833","article-title":"Polymeric micelles for the treatment of rheumatoid arthritis","volume":"36","author":"Yun","year":"2019","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0085","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2021.12.036","article-title":"Polymer nanotherapeutics to correct autoimmunity","volume":"343","author":"Su","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2015.02.003","article-title":"Nanoparticle-based autoimmune disease therapy","volume":"160","author":"Serra","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0095","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.jconrel.2022.08.020_bb0100","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2217\/nnm-2021-0182","article-title":"From traditional to novel treatment of arthritis: a review of recent advances in nanotechnology-based thermal therapy","volume":"16","author":"Shang","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0105","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","article-title":"Novel treatment strategies in rheumatoid arthritis","volume":"389","author":"Burmester","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0110","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1517\/14712598.2011.566856","article-title":"Kinoid of human tumor necrosis factor-alpha for rheumatoid arthritis","volume":"11","author":"Semerano","year":"2011","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0115","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1016\/j.vaccine.2013.06.101","article-title":"Strategies for active TNF-\u03b1 vaccination in rheumatoid arthritis treatment","volume":"31","author":"Jia","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0120","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1586\/14760584.2015.1026330","article-title":"Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis","volume":"14","author":"Rosenthal","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105164","article-title":"Antigen-specific tolerance approach for rheumatoid arthritis: past, present and future","volume":"88","author":"Page","year":"2021","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0130","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrrheum.2011.36","article-title":"Induction of immune tolerance in the treatment of rheumatoid arthritis","volume":"7","author":"Albani","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0135","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.ymthe.2017.03.032","article-title":"Peptide-conjugated nanoparticles reduce positive co-stimulatory expression and T cell activity to induce tolerance","volume":"25","author":"Kuo","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0140","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1016\/j.celrep.2016.08.033","article-title":"Reprogramming the local lymph node microenvironment promotes tolerance that is systemic and antigen specific","volume":"16","author":"Tostanoski","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0145","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1016\/j.vaccine.2014.08.016","article-title":"Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis","volume":"32","author":"Cappellano","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.biomaterials.2016.11.052","article-title":"Polyplexes assembled from self-peptides and regulatory nucleic acids blunt toll-like receptor signaling to combat autoimmunity","volume":"118","author":"Hess","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.procbio.2020.09.028","article-title":"Topical review on nano-vaccinology: biochemical promises and key challenges","volume":"100","author":"Zaheer","year":"2021","journal-title":"Process Biochem."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0160","first-page":"7163","article-title":"The new era of vaccines: the \u201cnanovaccinology\u201d","volume":"23","author":"Facciol\u00e0","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0165","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2021.03.001","article-title":"Preclinical models and technologies to advance nanovaccine development","volume":"172","author":"Peres","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0170","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1080\/14760584.2021.1984890","article-title":"Nanovaccine: an emerging strategy","volume":"20","author":"Das","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0175","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrrheum.2016.91","article-title":"Macrophage heterogeneity in the context of rheumatoid arthritis","volume":"12","author":"Udalova","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0185","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.molmed.2010.07.004","article-title":"Rheumatoid arthritis progression mediated by activated synovial fibroblasts","volume":"16","author":"Neumann","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0190","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0195","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1573397112666161230125317","article-title":"Biological agents in rheumatoid arthritis: a cross-link between immune tolerance and immune surveillance","volume":"14","author":"Talotta","year":"2018","journal-title":"Curr. Rheumatol. Rev."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0200","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.autrev.2019.05.007","article-title":"Challenges in the treatment of rheumatoid arthritis","volume":"18","author":"Conigliaro","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0205","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2217\/pgs.10.53","article-title":"Rheumatoid arthritis pharmacogenomics","volume":"11","author":"Marsal","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0210","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1021\/bm1008603","article-title":"Polysialic acid-based micelles for encapsulation of hydrophobic drugs","volume":"12","author":"Bader","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0215","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejps.2013.09.013","article-title":"Synthesis and evaluation of cyclosporine A-loaded polysialic acid-polycaprolactone micelles for rheumatoid arthritis","volume":"51","author":"Wilson","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","article-title":"The immunology of rheumatoid arthritis","volume":"22","author":"Weyand","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0225","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1021\/acs.biomac.2c00144","article-title":"Cyclic citrullinated peptide aptamer treatment attenuates collagen-induced arthritis","volume":"23","author":"Khatri","year":"2022","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0230","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.4049\/jimmunol.1402457","article-title":"Immune tolerance induction with multiepitope peptide derived from citrullinated autoantigens attenuates arthritis manifestations in adjuvant arthritis rats","volume":"194","author":"Gertel","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0235","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1021\/acs.nanolett.0c05110","article-title":"Nanoemulsions target to ectopic lymphoids in inflamed joints to restore immune tolerance in rheumatoid arthritis","volume":"21","author":"Li","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0240","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00281-017-0620-6","article-title":"Pre-symptomatic autoimmunity in rheumatoid arthritis: when does the disease start?","volume":"39","author":"Tracy","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cei.13256","article-title":"Dendritic cells, T cells and their interaction in rheumatoid arthritis","volume":"196","author":"Wehr","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0250","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.molmed.2018.12.008","article-title":"Neutrophils in rheumatoid arthritis: breaking immune tolerance and fueling disease","volume":"25","author":"O\u2019Neil","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0255","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0260","article-title":"B cells in rheumatoid arthritis: pathogenic mechanisms and treatment prospects","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0265","article-title":"Function and role of regulatory T cells in rheumatoid arthritis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0270","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/21645515.2019.1593085","article-title":"Vaccination against autoimmune diseases moves closer to the clinic","volume":"16","author":"van Eden","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0275","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0280","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/07853890801995298","article-title":"Vaccination with cytokines in autoimmune diseases","volume":"40","author":"Delavallee","year":"2008","journal-title":"Ann. Med."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0285","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00109-011-0757-z","article-title":"Peptide-MHC-based nanovaccines for the treatment of autoimmunity: a \u201cone size fits all\u201d approach?","volume":"89","author":"Clemente-Casares","year":"2011","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0290","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fimmu.2018.00281","article-title":"Tolerogenic nanoparticles induce antigen-specific regulatory T cells and provide therapeutic efficacy and transferrable tolerance against experimental autoimmune encephalomyelitis","volume":"9","author":"LaMothe","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0295","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1021\/acs.bioconjchem.7b00624","article-title":"Conjugation of transforming growth factor beta to antigen-loaded poly(lactide- co-glycolide) nanoparticles enhances efficiency of antigen-specific tolerance","volume":"29","author":"Casey","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0300","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nri1593","article-title":"Heat-shock proteins induce T-cell regulation of chronic inflammation","volume":"5","author":"van Eden","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0305","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/hum.2010.110","article-title":"Potent antirheumatic activity of a new DNA vaccine targeted to B7-2\/CD28 costimulatory signaling pathway in autoimmune arthritis","volume":"22","author":"Xue","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0310","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/07853890.2017.1407035","article-title":"Understanding modern-day vaccines: what you need to know","volume":"50","author":"Vetter","year":"2018","journal-title":"Ann. Med."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0315","doi-asserted-by":"crossref","first-page":"10621","DOI":"10.1021\/acsnano.8b05950","article-title":"Nanoparticles for immune stimulation against infection, cancer, and autoimmunity","volume":"12","author":"Singha","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0320","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.vaccine.2018.04.062","article-title":"Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases","volume":"36","author":"Zhang","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.06.008","article-title":"Extracellular traps and PAD4 released by macrophages induce citrullination and auto-antibody production in autoimmune arthritis","volume":"105","author":"El Shikh","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0330","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.intimp.2009.12.016","article-title":"CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine\/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model","volume":"10","author":"Zimmerman","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0335","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.vaccine.2008.11.090","article-title":"Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines","volume":"27","author":"Song","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0340","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1080\/21645515.2015.1073425","article-title":"Safety and immunogenicity of a novel therapeutic DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats","volume":"11","author":"Juan","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0345","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12951-019-0528-5","article-title":"Dynamic profiles, biodistribution and integration evaluation after intramuscular\/intravenous delivery of a novel therapeutic DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in vaccinated normal rodent","volume":"17","author":"Zhao","year":"2019","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112294","article-title":"Different protective efficacies of a novel antigen-specific DNA vaccine encoding chicken type collagen via intramuscular, subcutaneous, and intravenous vaccination against experimental rheumatoid arthritis","volume":"144","author":"Zhao","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0355","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/08916930601061603","article-title":"Tolerizing DNA vaccines for autoimmune arthritis","volume":"39","author":"Ho","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0360","doi-asserted-by":"crossref","first-page":"17345","DOI":"10.1038\/s41598-021-95193-2","article-title":"A fructosylated peptide derived from a collagen II T cell epitope for long-term treatment of arthritis (FIA-CIA) in mice","volume":"11","author":"Wenhart","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0365","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.39444","article-title":"An arthritis-suppressive and treg cell\u2013inducing CD4+ T cell epitope is functional in the context of HLA-restricted T cell responses","volume":"68","author":"de Wolf","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0370","doi-asserted-by":"crossref","first-page":"14134","DOI":"10.1073\/pnas.1206803109","article-title":"Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis","volume":"109","author":"MJCV","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0375","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/imm.12811","article-title":"Targeting of tolerogenic dendritic cells towards heat-shock proteins: a novel therapeutic strategy for autoimmune diseases?","volume":"153","author":"Jansen","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0380","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fimmu.2019.00279","article-title":"Heat shock proteins can be surrogate autoantigens for induction of antigen specific therapeutic tolerance in rheumatoid arthritis","volume":"10","author":"van Eden","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0385","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cytogfr.2020.03.002","article-title":"Selective inhibition of tumor necrosis factor receptor-1 (TNFR1) for the treatment of autoimmune diseases","volume":"55","author":"Zhang","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0390","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.clinthera.2018.04.016","article-title":"B lymphocytes in rheumatoid arthritis and the effects of anti-TNF-\u03b1 agents on B lymphocytes: a review of the literature","volume":"40","author":"Pala","year":"2018","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0395","article-title":"A rationally designed TNF-\u03b1 epitope-scaffold immunogen induces sustained antibody response and alleviates collagen-induced arthritis in mice","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113465","article-title":"Therapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trial","volume":"9","author":"Durez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0405","doi-asserted-by":"crossref","first-page":"8177","DOI":"10.1016\/j.biomaterials.2012.07.047","article-title":"Therapeutic role of a vaccine targeting RANKL and TNF-\u03b1 on collagen-induced arthritis","volume":"33","author":"Yuan","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0410","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.intimp.2018.09.022","article-title":"A novel recombinant RANKL vaccine prepared by incorporation of an unnatural amino acid into RANKL and its preventive effect in a murine model of collagen-induced arthritis","volume":"64","author":"Wu","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0415","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1016\/j.vaccine.2011.09.134","article-title":"Active immunization against IL-23p19 improves experimental arthritis","volume":"29","author":"Ratsimandresy","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0420","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.lfs.2013.04.012","article-title":"Suppression of murine collagen-induced arthritis by vaccination of synovial vascular endothelial cells","volume":"92","author":"Sawaguchi","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0425","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12967-016-0908-7","article-title":"Vaccination with endosomal unknown epitopes produces therapeutic response in rheumatoid arthritis patients and modulates adjuvant arthritis of rats","volume":"14","author":"Caruso","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0430","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1016\/j.vaccine.2017.05.009","article-title":"An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritis","volume":"35","author":"Mikecz","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0435","article-title":"Designation of a novel DKK1 multiepitope DNA vaccine and inhibition of bone loss in collagen-induced arthritic mice","volume":"2015","author":"Zhang","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0440","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/art.22316","article-title":"Vaccination with selected synovial T cells in rheumatoid arthritis","volume":"56","author":"Chen","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0445","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ijbiomac.2016.10.081","article-title":"Fc fragments of immunoglobulin G are an inductor of regulatory rheumatoid factor and a promising therapeutic agent for rheumatic diseases","volume":"95","author":"Sidorov","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0450","doi-asserted-by":"crossref","first-page":"8060375","DOI":"10.1155\/2020\/8060375","article-title":"Peptide-based vaccination therapy for rheumatic diseases","volume":"2020","author":"Wang","year":"2020","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0455","article-title":"Vaccination by two DerG LEAPS conjugates incorporating distinct proteoglycan (PG, Aggrecan) epitopes provides therapy by different immune mechanisms in a mouse model of rheumatoid arthritis","volume":"9","author":"Zimmerman","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0460","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1016\/j.vaccine.2012.08.023","article-title":"Nanovaccinology: the next generation of vaccines meets 21st century materials science and engineering","volume":"30","author":"Mamo","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0465","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41563-020-0793-6","article-title":"A DNA nanodevice-based vaccine for cancer immunotherapy","volume":"20","author":"Liu","year":"2021","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0470","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nmat4822","article-title":"Designer vaccine nanodiscs for personalized cancer immunotherapy","volume":"16","author":"Kuai","year":"2017","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0475","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2010.13108","article-title":"Anti-cytokine vaccination in autoimmune diseases","volume":"140","author":"Delavall\u00e9e","year":"2010","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0480","doi-asserted-by":"crossref","first-page":"12530","DOI":"10.1002\/jcp.28120","article-title":"Nanovaccine: a novel approach in immunization","volume":"234","author":"Gheibi Hayat","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0485","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.smim.2017.08.010","article-title":"Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases","volume":"34","author":"Prosperi","year":"2017","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/nano10112293","article-title":"An OMV-based Nanovaccine confers safety and protection against pathogenic Escherichia coli via both humoral and predominantly Th1 immune responses in poultry","volume":"10","author":"Hu","year":"2020","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0495","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1778","article-title":"Recent advances on transdermal delivery systems for the treatment of arthritic injuries: from classical treatment to nanomedicines","volume":"14","author":"Shang","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0500","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri3837","article-title":"Immune modulation by bacterial outer membrane vesicles","volume":"15","author":"Kaparakis-Liaskos","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0505","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0510","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0515","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2020.12.014","article-title":"Self-assembled mRNA vaccines","volume":"170","author":"Kim","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121051","article-title":"Novel approaches of the nanotechnology-based drug delivery systems for knee joint injuries: a review","volume":"608","author":"Younas","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0525","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.apsb.2021.03.013","article-title":"Nanomedicines for the treatment of rheumatoid arthritis: state of art and potential therapeutic strategies","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0530","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201800024","article-title":"Move to nano-arthrology: targeted stimuli-responsive nanomedicines combat adaptive treatment tolerance (ATT) of rheumatoid arthritis","volume":"14","author":"Liu","year":"2019","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.08.040","article-title":"Towards programming immune tolerance through geometric manipulation of phosphatidylserine","volume":"72","author":"Roberts","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0540","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/17425247.2020.1776259","article-title":"Polymeric nanostructure vaccines: applications and challenges","volume":"17","author":"Sim\u00f3n-V\u00e1zquez","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026684","article-title":"PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity","volume":"6","author":"Keijzer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107177","article-title":"Autoantigen-specific immune tolerance in pathological and physiological cell death: nanotechnology comes into view","volume":"90","author":"Tajbakhsh","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0555","article-title":"PD-L1- and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease. JCI","volume":"4","author":"Galea","year":"2019","journal-title":"Insight"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0560","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/art.10198","article-title":"Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance","volume":"46","author":"Kim","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13122091","article-title":"Nanovaccine delivery approaches and advanced delivery systems for the prevention of viral infections: from development to clinical application","volume":"13","author":"Cordeiro","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0570","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jconrel.2021.06.036","article-title":"Nanotechnology against COVID-19: immunization, diagnostic and therapeutic studies","volume":"336","author":"Hasanzadeh","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0575","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s13346-020-00818-0","article-title":"Nanotechnology-based antiviral therapeutics","volume":"11","author":"Chakravarty","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0580","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1021\/acsabm.9b00092","article-title":"Combinatorial, microparticle-based delivery of immune modulators reprograms the dendritic cell phenotype and promotes remission of collagen-induced arthritis in mice","volume":"2","author":"Allen","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0585","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/psc.2718","article-title":"Aldehyde modification and alum coadjuvancy enhance anti-TNF-\u03b1 autovaccination and mitigate arthritis in rat","volume":"21","author":"Bavoso","year":"2015","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0060001","article-title":"Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium","volume":"6","author":"Humby","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0595","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13075-016-0918-0","article-title":"In vitro eradication of citrullinated protein specific B-lymphocytes of rheumatoid arthritis patients by targeted bifunctional nanoparticles","volume":"18","author":"Pozsgay","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0600","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1021\/acschembio.8b01018","article-title":"Exploiting CD22 to selectively tolerize autoantibody producing B-cells in rheumatoid arthritis","volume":"14","author":"Bednar","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0605","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1021\/acschembio.1c00212","article-title":"Tolerogenic nanoparticles impacting B and T lymphocyte responses delay autoimmune arthritis in K\/BxN mice","volume":"16","author":"Srivastava","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0610","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/annrheumdis-2018-214489","article-title":"Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis","volume":"78","author":"von Loga","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0615","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1126\/science.aay3638","article-title":"A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis","volume":"371","author":"Krienke","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2022.08.020_bb0620","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41587-021-00880-0","article-title":"mRNA vaccines take on immune tolerance","volume":"39","author":"Wardell","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.08.020_bb0625","article-title":"Supramolecular nanostructures for vaccines","volume":"7","author":"Carmona-Ribeiro","year":"2021","journal-title":"Biomimetics (Basel)"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:26:43Z","timestamp":1759163203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922005259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":125,"alternative-id":["S0168365922005259"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.020","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From vaccines to nanovaccines: A promising strategy to revolutionize rheumatoid arthritis treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}